DotLab
PrivateLast Round
Accelerator
Sep 12, 2023
Est. Valuation
$5M
Total Funding Raised
$10.35M
Company Overview
DotLab operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was an Accelerator round in September 2023.
DotLab is a biotechnology company that develops non-invasive diagnostic tests for endometriosis using multiomics and machine learning.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Usage-Based SaaS, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DotLab Comparables
Compare DotLab with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HerAnova Lifesciences | 93% | |
| Milestone Gynomics Corp. | 87% | |
| Hera Biotech | 86% |
For institutional investors. Book with your work email.
DotLab Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 12, 2023 | ||||
| Series A | Jul 1, 2019 | ||||
| Accelerator | Jun 1, 2017 |
For institutional investors. Book with your work email.
DotLab Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Berkeley SkyDeck | Accelerator |
| Morgan Stanley Inclusive Ventures Lab | Accelerator |
| Kapor Capital | Accelerator |
| Wilson Sonsini Goodrich & Rosati | Series A |
| Tiger Global Management | Series A |
| Luxor Capital Group | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 31, 2026
Monthly visitors grew 149% MoM, reaching 3.4K.
- Jan 15, 2026
Grew 50% QoQ from 6 to 9 employees.
For institutional investors. Book with your work email.
DotLab Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about DotLab's valuation, stock price, and market status.
Is DotLab a public or private company?
DotLab is a private company.
What is the current stock price of DotLab?
DotLab is a private company, so its shares have no public market price. Caplight tracks DotLab's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DotLab worth (valuation)?
DotLab's valuation is estimated at $5.0M based on funding round data.
Can I buy DotLab stock?
DotLab shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DotLab's last funding round?
DotLab's most recent funding round was Accelerator on September 12, 2023.
Who are the main investors in DotLab?
Key investors in DotLab include Berkeley SkyDeck, Morgan Stanley Inclusive Ventures Lab, Kapor Capital, Wilson Sonsini Goodrich & Rosati, Tiger Global Management.
Will DotLab IPO soon?
No public IPO plans have been announced for DotLab.
How can I track DotLab secondary market activity?
Caplight tracks bids, offers, and trades in DotLab's shares on secondary markets.